Literature DB >> 9228267

Peripheral neuropathy in acrodermatitis chronica atrophicans - a late Borrelia manifestation.

E Kindstrand1, B Y Nilsson, A Hovmark, R Pirskanen, E Asbrink.   

Abstract

Clinical and/or neurophysiological signs of peripheral neuropathy were found in 64% of 63 consecutive untreated patients with the late borrelial manifestation acrodermatitis chronica atrophicans (ACA). The neuropathy frequency was significantly higher in the patients than in 30 age- and sex-matched control persons of whom 27% had neuropathy findings. The most common neuropathy in ACA was a symmetric distal sensory polyneuropathy. In a subgroup of patients with localized or asymmetric neuropathy, the changes were found more often in extremities with than without visible ACA lesions. Neuropathy symptoms, most often pain and/or paresthesia, were present in 64% of the patients, compared to in 13% of the control persons. Thus, both symptoms and signs of neuropathy were significantly more frequent in patients with untreated ACA than in control subjects.

Entities:  

Mesh:

Year:  1997        PMID: 9228267     DOI: 10.1111/j.1600-0404.1997.tb00222.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Lyme Neuroborreliosis.

Authors:  Sebastian Rauer; Stefan Kastenbauer; Volker Fingerle; Klaus-Peter Hunfeld; Hans-Iko Huppertz; Rick Dersch
Journal:  Dtsch Arztebl Int       Date:  2018-11-09       Impact factor: 5.594

Review 2.  Laboratory diagnosis of Lyme disease: advances and challenges.

Authors:  Adriana R Marques
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 3.  A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease.

Authors:  Gary P Wormser; Franc Strle; Eugene D Shapiro; Raymond J Dattwyler; Paul G Auwaerter
Journal:  Diagn Microbiol Infect Dis       Date:  2016-11-12       Impact factor: 2.803

4.  Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures.

Authors:  Aprielle B Wills; Alicen B Spaulding; Jennifer Adjemian; D Rebecca Prevots; Siu-Ping Turk; Carla Williams; Adriana Marques
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

5.  Management approaches for suspected and established Lyme disease used at the Lyme disease diagnostic center.

Authors:  Gary P Wormser; Donna McKenna; John Nowakowski
Journal:  Wien Klin Wochenschr       Date:  2016-01-14       Impact factor: 1.704

6.  Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients.

Authors:  K Ogrinc; V Maraspin; L Lusa; T Cerar Kišek; E Ružić-Sabljić; F Strle
Journal:  J Intern Med       Date:  2021-03-13       Impact factor: 13.068

7.  Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.

Authors:  Heidelore Hofmann; Volker Fingerle; Klaus-Peter Hunfeld; Hans-Iko Huppertz; Andreas Krause; Sebastian Rauer; Bernhard Ruf
Journal:  Ger Med Sci       Date:  2017-09-05

8.  Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis.

Authors:  Sebastian Rauer; Stephan Kastenbauer; Heidelore Hofmann; Volker Fingerle; Hans-Iko Huppertz; Klaus-Peter Hunfeld; Andreas Krause; Bernhard Ruf; Rick Dersch
Journal:  Ger Med Sci       Date:  2020-02-27

Review 9.  Comparison of Lyme Disease in the United States and Europe.

Authors:  Adriana R Marques; Franc Strle; Gary P Wormser
Journal:  Emerg Infect Dis       Date:  2021-08       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.